Sumitomo Mitsui DS Asset Management’s Roivant Sciences ROIV Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.26M	Buy	+61,728	New	+$2.24M	0.02%	516

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's ROIV Position: Q3 2026 in Review

Sumitomo Mitsui DS Asset Management opened a new position in Roivant Sciences (ROIV) in Q3 2026: 61,728 shares worth $2.26M. The stake represents 0.02% of the portfolio and ranks #516 among its holdings.

268 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

Sumitomo Mitsui DS Asset Management held 61,728 shares of Roivant Sciences worth $2.26M as of Q3 2026.
Roivant Sciences was a new Sumitomo Mitsui DS Asset Management position in Q3 2026.
Roivant Sciences made up 0.02% of Sumitomo Mitsui DS Asset Management's portfolio in Q3 2026, its #516 holding.
268 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.